Search the Web

Psychopharmacologic Therapies in Dermatology: An Update
Many patients who have skin disorders have associated psychosocial issues. Psychotropic agents with improved side-effect profiles are available to allow physicians who are not psychiatrists to manage patients who have psychiatric conditions with agents that are effective, simple to administer, and generally well tolerated. Full Text

Psychosomatic Factors in Dermatology

The identification of psychosomatic factors in dermatology has always been one of the principal themes in the history of this field.  Full Text

Stress and Psychoneuroimmunologic Factors in Dermatology
There is clinical and experimental evidence that the brain can start, influence, and stop biologic skin events. Studies suggest that the skin, as a relevant part of the “diffuse brain,” can modify the quality of perceptions and feelings. Full Text

Assessment scale used in vitiligo

During the last 5 years, several researchers have published their papers on different treatments for vitiligo. They used varied assessment scales to categorize the outcomes of their studies (Table I). Studies show a fair agreement in grading poor and excellent responses (0%-25% and 76%-100%, respectively) and a disagreement in grading other responses .  Full Text

Previous Articles:

  - Using Light in Dermatology: An Update on Lasers, Ultraviolet Phototherapy, and Photodynamic Therapy

  - Phototherapy treatment of psoriasis today

  - Lasers in dermatology: Four decades of progress

  - Laser therapy on darker ethnic skin